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ABSTRACT: Extracellular vesicles (EVs), including exosomes and
microvesicles (<200 nm), play a vital role in intercellular
communication and carry a net negative surface charge under
physiological conditions. Zeta potential (ZP) is a popular method
to measure the surface potential of EVs, while used as an indicator
of surface charge, and colloidal stability influenced by surface
chemistry, bioconjugation, and the theoretical model applied. Here,
we investigated the effects of such factors on ZP of well-
characterized EVs derived from the human choriocarcinoma JAr
cells. The EVs were suspended in phosphate-buffered saline (PBS)
of various phosphate ionic concentrations (0.01, 0.1, and 1 mM),
with or without detergent (Tween-20), or in the presence (10
mM) of different salts (NaCl, KCl, CaCl2, and AlCl3) and at different pH values (4, 7, and 10) while the ZP was measured. The ZP
changed inversely with the buffer concentration, while Tween-20 caused a significant (p < 0.05) lowering of the ZP. Moreover, the
ZP was significantly (p < 0.05) less negative in the presence of ions with higher valency (Al3+/Ca2+) than in the presence of
monovalent ones (Na+/K+). Besides, the ZP of EVs became less negative at acidic pH, and vice versa. The integrated data underpins
the crucial role of physicochemical attributes that influence the colloidal stability of EVs.
1. INTRODUCTION
Research on extracellular vesicles (EVs), including exosomes
and microvesicles, has witnessed a considerable boost over the
past few years. EVs play a vital role in transporting functional
molecules to the nearby or distant cells, thus facilitating
intercellular communication (Figure 1).1 Such communication
is not only essential for multicellular organisms but also being
increasingly recognized to play a role in the pathogenesis of
diseases.2 EVs are observed in biological fluids, such as serum,
urine, and breast milk, while most cell types are capable of
secreting exosomes under different conditions.3 Therefore,
conditioned medium is a widely used source to isolate EVs for
biological studies. The protein composition of exosomes is
closely related to their biogenesis as well as the physiological
conditions of the cells of origin.4 For instance, EVs are
enriched in membrane proteins, endosome-specific proteins
(Alix and TSG 101), tetraspanins (CD9, CD63, and CD81),
and heat-shock proteins (HSPs, such as HSP70 and HSP90).5
Such surface proteins, in addition to the cargo of molecules
present within the cores as payloads (e.g., RNA), have been
posited to be a promising inventory of biomarkers, and, thus,
exosomes may present a new possibility in oncotherapeutics in
addition to the diagnosis and treatment of many other
diseases.6
Different analytical methods are applied for a better
understanding of the EVs and their potential applications.8
However, it is challenging to analyze such heterogeneous
nanoscale particles, suggesting a need for different platforms to
characterize them. Traditionally, EVs have been characterized
in terms of physical properties, such as particle size,
concentration, surface charge, density, and biological proper-
ties, that is, their internal and external biomolecular
composition, for instance, membrane-associated antigens.8,9
For measurements of particle size, shape, and density of EVs,
techniques such as electron microscopy (EM),10 atomic force
microscopy,11 dynamic light scattering (DLS), tunable resistive
pulse sensing,12 flow cytometry,13 and nanoparticle tracking
analysis (NTA)14,15 are used.
A thorough understanding of the in vivo interactions of EVs
and their fate within the human body will improve their scope
in nanomedicine. However, interactions between the particles
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in dispersed systems can be quite complex. Much of this
complexity may arise from the differences in surface charge of
the particles. As nanoparticles (NPs), nonfunctionalized EVs
carry a net negative surface charge due to the nature of
molecules expressed at their surfaces (Figure S1). Zeta
potential (ZP), as an indicator of colloidal stability, is
influenced by the surface charge and can be measured from
the electrophoretic mobility in a suspension. Dispersed
systems, such as emulsions, suspensions, and colloidal
dispersions of NPs, contain electrically charged particles. In
such dispersed systems, the net surface charge of NPs, as
indicated by the ZP, determines the stability of particle−
particle and particle−medium interactions, including the
tendency of the particles to aggregate. Therefore, ZP is one
of the most useful tools to investigate the collective behavior of
NPs, including colloidal stability, such as EVs in dispersed
systems, and thus, holds promise as a method for studying the
activity of EVs in biological processes. For example, the surface
charge is known to influence different biological processes
associated with NPs, such as cellular uptake16 and cytotox-
icity.17
According to the von Smoluchowski equation, the electro-
phoretic mobility of charged particles (μe) is defined in terms
of the physical properties of dispersion and ZP.18 However,
depending on the allied factors, for example, particle size,
surface charge, and Debye length, other electrokinetic theories,
such as the Hückel, Henry, or O’Brien models, may be
required to explain the μe.
19 Under physiological conditions,
the surface of a biological plasma membrane carries a
negatively charged network of glycosylated proteins interca-
lated within the lipid bilayer.20 EVs and the plasma membrane
of cells possess a negative surface charge when suspended in a
neutral medium. The surface charge of EVs depends on a
multitude of factors: ionization of the membrane surface
groups, the chemistry of grafted chains (if any), protonated
states, inter- and intramolecular bonding, presence of H-bonds,
and ion adsorption from the electrolytes present in solution, to
name a few. Hence, the magnitude of ZP can fluctuate
depending on the electrochemical characteristics at the
particle−medium interface and is affected by numerous factors,
such as surface chemistry, pH, and ionic strength of the
medium, or the theoretical model applied. Although the effect
of such factors on the ZP of synthetic and nonbiological NPs
has been studied extensively, such investigations on bio-
logically derived NPs, such as EVs, are rare.21 The effects of
such factors on the ZP of EVs are unfortunately not
characterized enough despite their crucial role in stability,
pharmacokinetics, and release mechanism, which are essential
topics for preparing nanomedicinal formulations. In this paper,
we propose the ZP as an enabling characterization tool to
unravel the complexities of EV interactions with their
dispersant with tangible effects on colloidal stability and
repercussions from applied aspects, such as for theranostic
purposes. Thus, we aimed to investigate the effect of different
factors on the ZP of EVs secreted by the cultured human
choriocarcinoma (JAr) cells, while remaining focused primarily
on physical properties that affect the ZP, such as the
concentration of buffer, with or without surfactant, pH and,
ionic strength. Such investigations are essential if ZP
measurement protocols are to be reproducible, robust, and
conducive to further uses of EVs as a drug delivery system
(DDS).
Figure 1. Physiology of exosomes: fusion of the multivesicular bodies
(MVBs) with the cell membrane releases the exosomes decorated
with markers such as CD9, CD63, CD81, and HSP70 and composed
of intraluminal vesicles (ILVs) derived from the endoplasmic
reticulum (ER) as part of the secretory and/or endocytic pathways.
Exosomes carry nucleic acids, cytokines, and proteins (α-synuclein,
superoxide dismutase/SOD1, PrP) and achieve intercellular commu-
nication via a range of mechanisms, including uptake by the receptor
cell by clathrin-mediated pathway or pinocytosis, while the toxic
materials (e.g., β-amyloid) in the exosomes are cleared by the
microglia and macrophages. Adapted as a freely available open access
material under Creative Commons Attribution License (CC BY) from
Soria et al., 2017.7
Figure 2. Morphology of JAr EVs was observed using SEM (left panel) and TEM (right panel, inset: zoomed view of an EV elucidating structural
details). Scale bars are 200 nm for both the panels.
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2. RESULTS AND DISCUSSION
Interest in the EVs as a biologically derived nano-DDS has
gained momentum due to their emerging importance in
physiology and potential utility as theranostic agents. However,
especially for formulation purposes, it is essential to gain
control over the physicochemical attributes of such a
nanoparticulate system that is inherently heterogeneous and
lacks stability. It is established that the physicochemical
properties, including particle size and surface charge, influence
the way nanoscale materials behave and interact at biological
interfaces. Understanding such complex interactions in a nano-
bio environment requires methods for accurate and stand-
ardized characterization of the NPs,22 which unfortunately
continues to lack clarity and harmonization at a global scale.
Similarly, the characterization of EVs, like many other NPs, has
proved to be technically challenging due to a plethora of
reasons, including their heterogeneity.23 In this study, we
probed the role of various effects exerted by the dispersing
medium on the ZP of EVs secreted by cultured human
choriocarcinoma JAr cells. As a conditioned medium is a
widely used source to isolate EVs for biological studies, we
considered the use of JAr-cell-derived EVs to be apt for this
project. It is also worth noting here that JAr cells are used to
study trophoblast differentiation.
2.1. Characterization of the EVs. 2.1.1. Electron
Microscopy and NTA Measurements. The morphology and
size of the JAr EVs were determined by scanning electron
microscopy (SEM) and transmission electron microscopy
(TEM). Both the SEM and TEM images confirmed the overall
spherical shape of the EVs (Figures 2, S2, and S3), while the
mean diameter of the EVs (∼120 nm) matched the NTA data
(Figure 3, Scheme S1, Videos S1 and S2), and a polydispersity
index (PDI) of 1.11 was calculated (Scheme S2). Besides, the
TEM data showed that the EVs were overall spherical, cup-
shaped, and heterogeneous in size. TEM analysis revealed that
the size of EVs was 30−200 nm with a visible lipid bilayer
(Figure 2, right panel).
The results of SEM and TEM confirmed the presence of
EVs with a heterogeneity of size in the culture conditioned
media of JAr cells. EVs with broad size distribution are more
susceptible to lysis,24 and the present study investigated the
crucial issue of colloidal stability in EV suspensions under
physiologically relevant conditions and its vulnerability to a
range of fluctuations, such as the pH and ionic strength. These
factors are highly relevant to formulate EV-based nanomedical
preparations in a controlled and reproducible manner, which
has remained a less explored topic so far. Adequate separation
between the various EV-subpopulations, that is, exosomes and
microvesicles, is also necessary to allow individual ZP
measurements. The use of NTA is better suited for EV-
subpopulations as the measurements are done on a particle-by-
particle basis. However, the introduction of another method,
such as DLS, can be a useful verification tool for NTA results,
although both the techniques have their strengths and
weaknesses.
It is also important to note that the average hydrodynamic
size of the detected EVs was dependent on the chosen software
settings during NTA analysis. For example, our ZetaView
measurement settings were optimized to detect small particles.
As EVs are a heterogeneous mix of exosomes and micro-
vesicles, it was possible to adjust the NTA settings inclined
more toward detecting the larger particles, such as micro-
vesicles, by decreasing the frame rate. Such nuances should be
kept in mind during future research endeavors. Inclusion of
data arising from the aggregated particles can also contaminate
the particle size determined in NTA analysis25 and remains an
issue.
2.1.2. Western Blot Analysis. Western blot analysis for EV-
specific surface markers, such as CD9, CD63, CD81, and
HSP70 (Figure 4), showed that the JAr EVs were positive for
them.
The western blot analysis showed the presence of EV-
specific surface markers, such as CD9, CD63, CD81, and
HSP70a cytosolic protein, both in the JAr EVs and cell
lysates. The presence of a similar amount of these antigens was
observed both in the EV preparations and cell lysates,
indicating that the EVs were successfully isolated using size
exclusion chromatography (SEC). The presence of such
proteins on the surfaces decorated the EVs with anionic
sites. However, it also rendered the EV surfaces more complex
and challenging to exert control during their synthesis with
defined surface chemistry or the way EVs interact with their
biophysical surroundings. Furthermore, significant differences
in ZP were observed for exosomes derived from human cell
culture.26−29 Therefore, additional research should be under-
taken to investigate and compare the ZP data obtained under
Figure 3. NTA-based hydrodynamic size distribution expressed as the
mean ± standard deviation (SD) of the JAr EVs (n = 3). The PDI was
calculated to be 1.11.
Figure 4.Western blot analysis with EV-specific markers: EVs isolated
from the conditioned medium of human choriocarcinoma (JAr) cells
were probed/immunoblotted with CD9, CD63, CD81, and HSP70.
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different conditions or using different instruments to assess the
reported differences in such measurements on EVs.30
2.2. Effect of Buffer Content on the ZP of EVs. To
investigate the effect of buffer content on the ZP of EVs,
phosphate-buffered saline (PBS) was diluted to 1, 0.1, and 0.01
mM (phosphate) in water (pH 6.9). Regardless of the EV
concentration, the measured ZP showed a significant shift
toward less negative values in the presence of higher
concentrations of PBS (F(2) = 166.4, p < 0.001; Figure 5).
There was no significant effect of EV concentration (F(2) =
1.04, p = 0.434) on the respective PBS concentrations. Post
hoc Tukey’s test revealed that for each of the EV
concentrations, ZP was significantly less negative at 1 mM
compared to 0.01 mM PBS (all p < 0.01).
The state of dispersion can alter the surface chemistry of the
NPs and, thereby, their surface charge. In this study, the ZP
values of EVs became less negative as the PBS concentration
increased. This effect can be attributed to the presence of a
higher number of counterions in 1 mM PBS compared to the
two other 10× serial dilutions. The presence of counterions
can be linked with the higher conductivity noticed at a higher
molar concentration of PBS (1 mM [1070−1151 μS/cm] >
0.1 mM [93−145 μS/cm] > 0.01 mM [26−46 μS/cm]). Such
high conductivity at 1 mM PBS concentration may, thus, affect
the ionic ambiance of the NPs. Specifically, the thickness of an
electrical double layer (EDL) surrounding the particle has an
inverse relationship with the ionic strength of the surrounding
medium since an excess of ions can hold the EDL more
robustly, hence causing shrinkage of the EDL. Additionally, a
higher conductivity of the dispersing medium can influence the
stability of EDL by lowering the repulsive forces between the
EVs, which in turn augments the interparticulate interactions
due to forces acting at a molecular scale, such as the Van der
Waals force; thus interfering with the stability of the colloidal
system of EVs and reflected in a less negative ZP value. Our
results corroborated well with some of the previous studies
conducted under similar lines.26,27 However, contrary to our
findings, a previous study showed that decreasing molar
concentrations of PBS led to less negative ZP of normal
trabecular meshwork-derived exosomes.31 Such differences in
observation might have appeared due to several factors, such as
the range of PBS concentrations tested, type of EVs studied
along with particle concentration, dispersing medium for the
formation of EV-complexes, etc. Overall, the dependence of ZP
on EV concentration was observed in each of the PBS
concentrations.
Nevertheless, the results indicated that there was a
concentration range where the ZP was affected by the
particulate concentrations of EVs suspended in 0.1 mM PBS
buffer content. The two lower concentrations of EVs (106/mL
and 107/mL) showed a shift in ZP to less negative values
compared to the highest concentration of EVs (108/mL)
resuspended in the same buffer content. The shift in ZP values
at lower concentrations may be accompanied by the presence
of higher electrophoretic mobility of EVs in dispersing medium
and low scattering signals. In other words, NPs were too
diluted at lower concentrations and, hence, the particles failed
to achieve a satisfactory signal-to-noise ratio. Thus, the net
effect on ZP may change with the concentration of NPs and
dispersing medium. Therefore, it is advisable to limit
aggregation by decreasing the NP concentration up to an
optimal standard that still delivers an adequate signal-to-noise
ratio. In general, it is difficult to provide a relationship between
ZP and NP concentration. Additionally, osmotic effects due to
the varying ionic strength can induce swelling or shrinkage of
the EVs, which in turn can also affect ZP.
2.3. Effect of Detergent on the ZP of EVs. The addition
of 0.03% Tween-20 induced a shift toward less negative ZP
values, which appeared to be overall consistent across the
different EV and PBS concentrations (Figure 6). As such, there
was a highly significant additive effect of Tween (F(2) =
279.64, p = 0.004). The effect of Tween was significantly
dependent on buffer concentration (F(2) = 10.2, p = 0.027)
but not EV concentration (F(2) = 0.442, p = 0.67). Post hoc
Tukey’s test showed the effect of Tween to be significant (p <
0.05) at all PBS dilutions and EV concentrations except the
measurements at 1 mM PBS and 108/mL (p = 0.4)
concentration.
The present study was also designed to determine the effect
of detergents on the ZP of EVs. To assess possible interactions
of complex adsorbates at the solid−liquid and liquid−liquid
interfaces, we used Tween-20, a widely used non-ionic
detergent, to determine the degree of adsorption onto the
EVs. The addition of detergent to the buffer solutions led to
less negative ZP values. In general, EVs suspended in PBS and
supplemented with 0.03% Tween-20 showed less negative ZP,
Figure 5. ZP of JAr EVs (mean ± SD, n = 9) expressed as a function
of different concentrations of EVs (106/mL (□), 107/mL (light gray
boxes), and 108/mL (dark gray boxes)) and PBS (0.01, 0.1, and 1
mM) at pH 6.9. All of the data points at 1 mM were significantly
different (p < 0.05) than those for the most dilute, that is, 0.01 mM,
dispersions carrying 0.138 M and 0.0027 M NaCl and KCl,
respectively, and thus were marked with an asterisk (*) symbol.
Figure 6. ZP (mean ± SD, n = 9) of JAr EVs under different buffer
conditions. The EVs were suspended in PBS of various concentrations
(0.01, 0.1, and 1 mM), without (gray boxes) or with (□) Tween-20
(0.03%), at pH 6.9 under three different particle concentrations (106/
mL, 107/mL, and 108/mL).
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which was more apparent at a higher molar concentration of
PBS. However, the presence of Tween-20 did not affect the ZP
for all of the EV and buffer combinations. For example, there
was hardly any effect of Tween-20 on ZP measurements in 1
mM PBS at the highest EV concentration (108/mL). It is
known that non-ionic detergents or surfactants are capable of
breaking lipid−lipid and lipid−protein interactions more than
protein−protein interactions and rarely denature proteins.32
Such surfactants are used to control the surface charge and/or
the hydrophobic−hydrophilic balance at particle surfaces, thus
influencing the colloidal stability. Here, the addition of a non-
ionic detergent into PBS presumably led to its adsorption on
the EVs and deterred colloidal stability. The further reduction
in the ZP of EVs was likely caused by the ability of the
surfactant to be adsorbed onto EV surfaces/lipid bilayer near
the critical micellar concentration (CMC). Moreover, it is
possible that the presence of free fatty acids (FFAs), which are
known to interact with Tween-20, may impart a negative ZP.
Overall, the ZP of EVs in the suspending medium might have
stabilized due to non-ionic interactions of detergent in the
presence of low molar concentrations of PBS interfering with
the steric repulsion between EVs. Although a study showed the
effect of detergents on the susceptibility of EV lysis,24 no
previous study investigated the effect of detergents on ZP or its
correlation to the colloidal stability of EVs.
2.4. Effect of Ionic Valency and Ionic Strength on the
ZP of EVs. The ZP of EVs became less negative in the
presence of trivalent Al3+ (mean ZP, −33 mV; T(8) = 13.52, p
< 0.001) and divalent Ca2+ (mean ZP, −24 mV; T(8) = 9.86, p
< 0.001) but was not affected by the monovalent Na+ and K+
ions (Figure 7, left panel). The ZP value decreased with
increasing ionic strength (Figure 7, right panel).
It is worth mentioning here that apart from ZP, the critical
coagulation concentration (CCC), that is, the minimum
concentration of the counterions required to induce coagu-
lation in a colloidal suspension, may also be a crucial parameter
to assess colloidal stability. The CCC values may be calculated
not only based on the energy33 or force34 of the interactions
occurring within a dispersion but also from the electrophoretic
mobility.35 Furthermore, the factors that influence the ZP and
included in this study might provide with essential cues on the
fate of the EVs within cellular cytoplasm known to undergo
fluctuations regarding their ionic strength and pH.36
The ZP of JAr EVs became significantly less negative in the
presence of trivalent ions compared to the monovalent or
divalent ones. The decrease in ZP magnitude in response to
higher-valency ions is likely due to the compression of the EDL
surrounding EV surfaces resulting from an increased binding
by the ions of higher valency. Thus, the magnitude of ZP, or
the colloidal stability, of JAr EVs at neutral pH decreased in the
following order: Al3+ > Ca2+ > Na+, K+. According to the
DLVO (Derjaguin, Landau, Verwey, and Overbeek) model,
the interaction between the particles in a system is the sum of
the attractive and repulsive forces. If the net repulsive forces
exceed the net attractive forces, the colloidal system gains
stability as it deters close contact within the particles,37 and vice
versa. Unfortunately, for the monovalent ions, such as the N+
and K+, the DLVO model fails to predict the CCC accurately
due to its dependence on valency and concentration of ions
present in the dispersion. In reality, though, the CCC depends
on multiple factors, including the properties of co-ions and
counterions. Therefore, the Hofmeister series provides a better
prediction of colloidal stability than the DLVO model in case
of monovalent ions.38 For multivalent ions, however, the
DLVO model predicts the CCC as per the Schulze−Hardy
rule, which states that an ion causing coagulation in a colloidal
dispersion carries an opposite charge to the colloidal particles
and its coagulating power increases with valency.39 The ZP of
JAr EVs became less negative with increasing valency of ions
that compressed the EDL and, thus, facilitated the proximity
between the particles, resulting in aggregation, as reflected in
less negative ZP. The presence of monovalent ions Na+, K+,
and Cl− did not affect the measured ZP of EVs. Although some
similar studies based on the effect of proteins are available,40 to
the best of our knowledge, this study is the first to highlight the
role of ionic valency in the colloidal stability of EV dispersions.
2.5. Effect of pH on the ZP of EVs. Overall, ZP became
more negative as pH increased (F(2) = 21.66, p = 0.007;
Figure 8) but appeared to be more variable at alkaline and
acidic pH values than at neutral pH 7. Post hoc Tukey’s tests
showed that ZP was significantly more negative at pH 10
compared to pH 4 at all PBS concentrations (all p < 0.01). The
effect of pH was not influenced by the buffer content, though
(F(4) = 1.45, p = 0.304).
Our study showed the effect of pH on the ZP of EVs: the ZP
became less negative at acidic pH with more propensity toward
Figure 7. ZP (mean ± SD, n = 9) of JAr EVs: (left panel) in the
presence of 10 mM different chloride salts (NaCl, KCl, CaCl2, and
AlCl3) in 0.01 mM PBS (pH 6.9) and (right panel) at various ionic
strengths. The ZP values in the presence of CaCl2 and AlCl3 (ionic
strength 6 × 103) were significantly different (p < 0.05) than the
control and, thus, were marked with an asterisk (*) symbol.
Figure 8. ZP measurements (mean ± SD, n = 9) of 108 EVs/mL
expressed as a function of pH (acidic pH 4, neutral pH 7, and basic
pH 10) in the presence of 0.01 mM (■), 0.1 mM (gray boxes), and 1
mM (□) PBS. All of the data points at 1 mM were significantly
different (p < 0.05) than those of the most dilute, that is, 0.01 mM,
dispersions and thus were marked with asterisk (*) symbols.
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aggregation, and vice versa. One hypothesis is that primarily
due to the presence of lipids and proteins, including the CD
antigens, EVs harbor ample anionic sites on their surfaces,
resulting in a negative ZP with a magnitude of 30−40 mV.
However, the presence of excess protons (H+) under acidic
conditions most likely neutralized some of the anionic sites on
EV surfaces and compromised the electrostatic interparticulate
repulsive forces to destabilize the system, as got noticed in
lesser negative ZP values. In contrast, the presence of an excess
base under basic conditions unmasked additional negative sites
on the EV surfaces by deprotonation of the surface groups,
thus adding to the interparticulate repulsive forces, and
enhanced colloidal stability reflected by more negative ZP
values. Some studies have reported the effect of multiple
storage conditions, such as the pH, particle concentration,41
EV isolation,42 and overall colloidal stability. Our data
provided a conceptual framework to explain such findings,
prioritized physicochemical characterization for a successful
translational of the EVs, and informed researchers in the field
to ascertain potential risks associated with the nature of EVs.
3. CONCLUSIONS
This study aimed to check the applicability of ZP for the direct
characterization of EVs. We used EVs secreted from the human
choriocarcinoma JAr cells as a model system. Higher
concentrations of multivalent ions, both cationic (Ca2+, Al3+)
and anionic (phosphate), decreased the negative value of ZP at
all EV concentrations (106/mL, 107/mL, and 108/mL)
investigated. The influence of monovalent ions on ZP values
at their concentrations up to 10 mM (K+, Na+, and Cl−) was
minimal. The ZP of the studied EVs was dependent on the pH
of the solution. Besides, the presence of detergent (Tween-20)
considerably decreased the negative value of ZP.
Our data indicated a need for the characterization of EVs
under standardized ZP measurement protocols. Without such
protocols, or reporting the precise experimental conditions
used while measuring ZP, the obtained data will be
irreproducible and hardly bear any value from a translational
perspective or characterization of the EVs.
4. EXPERIMENTAL SECTION
4.1. Materials. Dulbecco’s PBS (Sigma-Aldrich Co., St.
Louis), Tween-20 (0.0003% Arsenic, 0.0005% Copper, Fisher
BioReagents, Fair Lawn), hydrochloric acid (Honeywell
GmbH, Seelze, Germany), sodium hydroxide (potassium
≤0.02%, ≥98%, Sigma-Aldrich Co., St. Louis), sodium chloride
(Merck KGaA, Darmstadt, Germany), potassium chloride
(≥99%, Fisher Chemical, Loughborough, U.K.), calcium
chloride (≥93%, Sigma-Aldrich Co., St. Louis), and aluminum
chloride (≥99%, Chem-Supply Pty Ltd, Gillman, Australia)
were used as received without any further purification.
4.2. Cell Culture. The human choriocarcinoma cell line
(JAr) from the first trimester trophoblasts was acquired from
the American Type Culture Collection (ATCC, HTB-144,
Teddington, U.K.). JAr cells were cultured in a T75 flask in
Roswell Park Memorial Institute (RPMI) 1640 media (Gibco,
Scotland) supplemented with 1% penicillin/streptomycin (P/
S, Gibco 15140122, Bleiswijk, Netherlands), 1% L-glutamine
(Sigma, 59202C, St. Louis), and 10% fetal bovine serum (FBS,
Gibco, 10500064) at 37 °C under moist 5% CO2-rich
conditions. At 80% confluence, the conditioned medium was
removed, and the cells were washed with 10 mL of
nonsupplemented RPMI 1640 media to remove traces of
FBS. Nonsupplemented RPMI 1640 medium was replaced
with fresh RPMI 1640 medium supplemented with 1%
penicillin/streptomycin, 1% L-glutamine, and 10% EV-depleted
FBS. Cells were cultured for 24 h at 37 °C and 5% CO2. After
incubation, the conditioned medium was collected for EV
isolation. We have submitted all relevant data of our
experiments to the EV-TRACK knowledgebase (EV-TRACK
ID: EV190091).43
4.2.1. EV-Depletion of the FBS. The depletion of EVs in
FBS was carried out using a methodology proposed earlier.44
Briefly, FBS was ultrafiltered using Amicon Ultra-15 centrifugal
filter devices (100 kDa cutoff, MerkMillipore, Darmstadt,
Germany) for 30 min at 5000g. The filtrate was collected and
measured for particle concentration using NTA. For this study,
the vesicle-depleted conditioned medium was used to isolate
and purify EVs by SEC, and the EV preparations met the
optimal quality as per the guidelines prescribed by the
International Society for Extracellular Vesicles (ISEV).45
4.2.2. EV-Purification. The conditioned medium was
centrifuged first at 400g for 10 min, while the supernatant
from two successive centrifugation steps (4000g and 10 000g
for 10 min) to remove cell debris and apoptotic bodies was
retained. The collected conditioned medium was concentrated
to 500 μL with Amicon Ultra-15 centrifugal filter devices (10
kDa cutoff, MerkMillipore, Darmstadt, Germany), and EVs
were isolated from the concentrated media using SEC in a
cross-linked 4% agarose matrix of 90 μm beads (Sepharose 4
Fast Flow, GE HealthCare Bio-Sciences AB, Uppsala, Sweden)
in a 10 cm gravity column calibrated with PBS. The EV-
enriched fractions 6−9 (volume 0.5 mL) were collected and
concentrated further using Amicon Ultra-15 centrifugal filter
devices (10 kDa cutoff), as described previously.46 Isolated
EVs were quantified using NTA (ZetaView, Particle Metrix
GmbH, Inning am Ammersee, Germany).
4.3. NTA on the EVs. NTA was conducted using a
ZetaView PMX 110 V3.0 instrument (Particle Metrix GmbH,
Germany), while the data were analyzed by ZetaView NTA
software. Operating instructions of the manufacturer were
followed before calibrating the instrument with a known
concentration of 100 nm polystyrene nanoparticles (Applied
Microspheres B.V., Netherlands). The standards were
suspended in particle-free water, whereas the EV samples
were diluted 1:1000 with Milli-Q (MQ) water for analyses.
Particles were counted and size-distributed at three cycles of
11 frames per cycle under a sensitivity of 85 and shutter value
of 100.
4.4. ZP Measurements. The ZP of JAr EVs was measured
thrice at 25 °C under the following settings: sensitivity of 85, a
shutter value of 70, and a frame rate of 30 frames per second,
while ZetaView software was used to collect and analyze the
data.
4.5. SEM. A drop of the JAr EV suspension was deposited
on an aluminum foil for overnight drying and imaged the
following day in a Hitachi S-4300 SEM microscope after
sputter-coating the samples with gold.
4.6. TEM. JAr EVs for TEM imaging were prepared as
described before46 with modifications. Briefly, 20 μL of the EV
suspension was deposited on formvar-carbon-coated 200 mesh
copper grids (Agar Scientific, Essex, U.K.) for 20 min and fixed
in Karnowski fixatives (a mixture of 2% paraformaldehyde and
1% glutaraldehyde) for 5 min. Next, EVs were contrasted for 5
min in uranyl oxalate [1:1 mixture of 4% uranyl acetate
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(21447-25, Polysciences, Warrington) and 0.15 M oxalic acid
(75688, Sigma-Aldrich, Schnelldorf, Germany)] and embed-
ded in a mixture (9:1) of 2% methylcellulose (M6385, Sigma-
Aldrich, Schnelldorf, Germany) and 4% uranyl acetate (21447-
25, Polysciences, Warrington). The EVs were imaged using a
JEM 1400 TEM (JEOL Ltd. Tokyo, Japan, with Morada TEM
CCD camera, Olympus, Germany) at 80 kV.
4.7. Western Blot Analysis. Purified JAr EVs were
concentrated to 200 μL with an Amicon Ultra-15 centrifugal
filter unit (10 kDa cutoff, Millipore, Merck KGaA, Darmstadt,
Germany). The concentrated sample was then transferred to a
fresh tube, and EV-proteins were precipitated by adding 200
μL of water, 400 μL of methanol, and 100 μL of chloroform.
The solution was briefly vortexed and centrifuged at 14 000g
for 5 min at room temperature. Proteins formed a white
precipitate at the interphase of the top aqueous layer. After
removing the top layer, another 400 μL of methanol was added
to the precipitated proteins and was centrifuged again. The
pellets were air-dried and resuspended in 0.5% sodium dodecyl
sulfate (SDS), and protein concentrations were determined by
the Bradford assay. JAr cells were lysed in lysis buffer (50 mM
Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, and 1×
protease inhibitors) on ice for an hour. Samples were
centrifuged at 14 000g for 5 min at 4 °C, and the protein
concentration in supernatants was determined by the Bradford
assay. Either reducing or nonreducing Laemmli buffer was
added to the protein samples and heated for 5 min at 95 °C.
Then, 50 μg of protein was used for the detection of HSP70
(under reducing conditions), and 30 μg of protein was used for
the detection of CD63, CD9, and CD81 (under nonreducing
conditions). Protein samples were resolved in 12% SDS-
polyacrylamide gel electrophoresis (PAGE) according to the
standard protocol and transferred onto poly(vinylidene
difluoride) membranes (Thermo Scientific, Michigan). The
membrane was blocked in 5% nonfatty dry milk in PBS-T
(0.05% Tween-20, Thermo Scientific, Michigan) for 1 h at
room temperature followed by incubation with the primary
anti-CD63 (556019, 1:1000, BD Biosciences, New Jersey),
anti-CD9 (sc-59140, 1:250, Santa Cruz Biotechnology Inc.,
Dallas, TX), anti-HSP70 (NB110-61582, 1:1000, Novus
Biologicals, Abington, U.K.), and anti-CD81 (555675, 1:500,
BD Biosciences, New Jersey) antibodies overnight at 4 °C in
5% milk-PBS-T solution. Incubation with the horseradish
peroxidase-conjugated goat anti-mouse secondary antibody
(G21040, 1:10 000, Thermo Fisher Scientific, Eugene) was
performed at room temperature for an hour. In between
incubations, the membrane was washed thrice for 5 min in
PBS-T. Protein bands were detected using the ECL SelectTM
western blotting detection reagent (GE Healthcare, Buck-
inghamshire, U.K.) with an ImageQuantTM RT ECL imager
(GE Healthcare, Buckinghamshire, U.K.).
4.8. Statistical Analysis. Statistical analyses were
performed using R (version 3.6.1, R foundation for statistical
computing, Vienna, Austria). The effects of different
conditions were assessed using nested one-way or two-way
ANOVAs with a “replicate” error term included. Tukey’s
multiple comparison tests were used for specific intergroup
comparisons (“emmeans package”). Data are presented as
mean ± SD (n = 3), while p-values <0.05 were taken as
statistically significant and were marked with an asterisk (*)
symbol. The data were plotted using the ggplot2 package in R
and OriginPro 2015 software (OriginLab Corp., MA).
4.9. Experimental Design. 4.9.1. Effect of Buffer
Concentration on the ZP of EVs. To study the effect of
PBS concentration on the ZP of EVs, 20 μL of the JAr EVs was
suspended in a final volume of 200 μL of PBS diluted in MQ
water in a ratio of 1:1000 to obtain an initial concentration in
the range of 109 particles/mL. ZetaView NTA was used to
measure the hydrodynamic size profile and concentration of
JAr EVs suspended in 1:10 and 1:100 diluted PBS/MQ. Using
such PBS dilutions (1, 0.1, and 0.01 mM), samples with
diverse EV concentrations, ranging from 106 to 108 EVs/mL,
were prepared and incubated at 4 °C for 3 h on a BIOSAN
Multi Bio RS-24 programmable rotator (BioSan, Riga, Latvia)
set at 30 rpm. After the incubation, the pH of the suspension
medium was adjusted to 6.9 with a pH meter (SevenCom-
pactTM pH/Ion S220, Mettler-Toledo AG, Schwerzenbach,
Switzerland) by addition of 0.1 M HCl/NaOH. The ZP of JAr
EV samples was measured using ZetaView software. The
experiments were performed on 3 days, and on each day,
triplicates of ZP measurements were taken for individual
samples with different concentrations of JAr EVs.
4.9.2. Effect of the Presence of Detergent on the ZP of
EVs. To test whether the presence of detergent in the PBS
buffer affected the ZP of EVs, 20 μL of the JAr EVs was
suspended in a final volume of 200 μL of 1:1000 diluted in
PBS/MQ containing 0.03% Tween-20 (BP337, Fisher BioRe-
agents, Fair Lawn) to obtain an initial concentration in the
range of 109 particles/mL. JAr EVs were also suspended in PBS
diluted in 0.03% Tween-20/MQ in the ratios of 1:10 and
1:100. Using the same PBS concentrations (1, 0.1, and 0.01
mM), samples with different EV concentrations ranging from
106 to 108 EVs/mL were prepared and incubated further at 4
°C for 3 h on a BIOSAN Multi Bio RS-24 rotator. After
incubation, the pH of the suspension medium was adjusted to
6.9. The experiments were performed on 3 days and each day
with triplicates of ZP measurements performed for each
concentration of JAr EVs.
4.9.3. Effect of Ionic Strength of the Media on the ZP of
EVs. Different chloride salts were used to test the effect of ionic
strength on the ZP of EVs. For both the control and test
samples, JAr EV suspensions, with an initial concentration of
109 EVs/mL in PBS diluted in MQ at the ratio of 1:1000 to
obtain a final concentration in the range of 108 EVs/mL, were
used. Subsequently, 20 μL of JAr EVs (109 particles/mL) was
resuspended in 200 μL of PBS/MQ in a ratio of 1:1000 and
incubated at room temperature for an hour on a BIOSAN
Multi Bio RS-24 rotator. For the test samples, the following
chloride salts were used: NaCl, KCl, CaCl2, and AlCl3, with
increasing valency of the cations, that is, monovalent sodium
and potassium, divalent calcium, and trivalent aluminum, while
a final concentration of 10 mM was added separately into the
EVs suspended in PBS/MQ (1:1000). Both the control and
test samples had a final concentration in the range of 108
particles/mL. After the incubation, the pH of the suspension
was adjusted to 6.9, using 0.1 M HCl/NaOH. The EVs were
appropriately diluted in the respective buffer to fit into a
predefined limit of the minimum number of detected particles
(at least 100 particles/image frame). Later, the ZP of JAr EVs,
with or without the presence of cations, was measured as
described before in the paper.
4.9.4. Effect of pH on the ZP Measurements of the EV. To
study the effect of pH on the ZP, 10 μL of JAr EVs (∼2.2 ×
1010 particles/mL) was suspended in a final volume of 1000 μL
of PBS diluted in MQ at a ratio of 1:1000 to obtain a
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concentration in the range of 108 particles/mL during
incubation. ZetaView was used to conduct the hydrodynamic
size profiling and determination of the concentration of JAr
EVs. Similarly, JAr EVs were also suspended in PBS diluted in
MQ at the ratios of 1:10 and 1:100. Using such PBS
concentrations (1, 0.1, and 0.01 mM), samples with the same
EV concentration of 108 EVs/mL were prepared and incubated
at 4 °C for 3 h on a BIOSAN Multi Bio RS-24 rotator. After
the incubation, the pH of the suspension was adjusted to 4, 7,
and 10 using a pH meter with the addition of 0.1 M HCl/
NaOH. EVs were diluted in the respective buffer to fit into a
predefined limit of a minimum number of detected particles in
the NTA ZetaView instrument, and the ZP of the EVs was
measured as mentioned above. The experiments were
performed on 3 days and each day in triplicates for each
concentration of EVs.
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